drugset / Trial / NCT01096472

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

NCT01096472

Phase 2 Completed 120 enrolled Almirall, S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to determine the efficacy and safety of a topical application of the combinational cream LAS41003 compared to application of its mono-substances after once daily treatment in patients with inflammatory tinea pedis.

Timeline

Start
2010-02
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject LAS41003 Unknown Topical
Comparator Octenidine Small molecule Topical
Comparator Prednicarbate Small molecule Topical

Indications